Abstract
Future Role of the Clinical Lab in Population Health.
Highlights
The COVID-19 pandemic has illustrated how today’s health care environment and current delivery models are ill-equipped to address community health and public safety
The movement defines the future valuation of clinical laboratory services and evolution of the clinical laboratory business model
Laboratories can move from a transactional commodity delivering test results for sick care, defined as Clinical Lab 1.0, to an integrative component of value-based care providing clinical insights, defined as Clinical Lab 2.0.5 Project Santa Fe Foundation (PSFF) today actively supports organizations globally to demonstrate these principles
Summary
Consumer activation may create opportunities to improve patients’ access to care and inform their health care providers Examples of this in the COVID-19 environment could include engaging specified patients to quarantine when needed or to continue routine health care with confidence during the pandemic for preexisting conditions. Use of longitudinal data to develop actionable insights for members of the health care ecosystem (provider, patient, payer, health system) might include identification of clinical risk from comorbidities, gaps in care for chronic conditions, and facilitation of health care interventions using the laboratory’s infrastructure. Clinical Lab 2.0 insights may include the provision of more actionable and understandable laboratory results for the provider, patient, and caregivers This supports consumer engagement by empowering patients to manage their chronic disease. The domain knowledge of laboratory medicine, its vast patient touch points, physical proximity to patients, and real-time insights all support the clinical action platform
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
